Altamira Therapeutics Stock Total Debt
Altamira Therapeutics fundamentals help investors to digest information that contributes to Altamira Therapeutics' financial success or failures. It also enables traders to predict the movement of Altamira Stock. The fundamental analysis module provides a way to measure Altamira Therapeutics' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Altamira Therapeutics stock.
Altamira |
Altamira Therapeutics Company Total Debt Analysis
Altamira Therapeutics' Total Debt refers to the amount of long term interest-bearing liabilities that a company carries on its balance sheet. That may include bonds sold to the public, notes written to banks or capital leases. Typically, debt can help a company magnify its earnings, but the burden of interest and principal payments will eventually prevent the firm from borrow excessively.
Current Altamira Therapeutics Total Debt | 99.66 K |
Most of Altamira Therapeutics' fundamental indicators, such as Total Debt, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Altamira Therapeutics is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
In most industries, total debt may also include the current portion of long-term debt. Since debt terms vary widely from one company to another, simply comparing outstanding debt obligations between different companies may not be adequate. It is usually meant to compare total debt amounts between companies that operate within the same sector.
CompetitionBased on the latest financial disclosure, Altamira Therapeutics has a Total Debt of 99.66 K. This is 100.0% lower than that of the Biotechnology sector and 99.97% lower than that of the Health Care industry. The total debt for all United States stocks is 100.0% higher than that of the company.
Altamira Total Debt Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Altamira Therapeutics' direct or indirect competition against its Total Debt to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Altamira Therapeutics could also be used in its relative valuation, which is a method of valuing Altamira Therapeutics by comparing valuation metrics of similar companies.Altamira Therapeutics is currently under evaluation in total debt category among its peers.
Altamira Fundamentals
| Return On Equity | -3.69 | |||
| Return On Asset | -0.57 | |||
| Current Valuation | 860.75 K | |||
| Shares Outstanding | 3.78 M | |||
| Shares Owned By Insiders | 0.52 % | |||
| Shares Owned By Institutions | 3.13 % | |||
| Number Of Shares Shorted | 50.63 K | |||
| Price To Book | 0.08 X | |||
| Price To Sales | 0.64 X | |||
| Gross Profit | (2.18 M) | |||
| EBITDA | (1.35 M) | |||
| Net Income | (3.87 M) | |||
| Cash And Equivalents | 984.19 K | |||
| Cash Per Share | 1.29 X | |||
| Total Debt | 99.66 K | |||
| Debt To Equity | 0.04 % | |||
| Current Ratio | 0.77 X | |||
| Book Value Per Share | 2.37 X | |||
| Cash Flow From Operations | (11.51 M) | |||
| Short Ratio | 0.52 X | |||
| Earnings Per Share | 1.82 X | |||
| Target Price | 4.92 | |||
| Number Of Employees | 10 | |||
| Beta | 2.44 | |||
| Market Capitalization | 1.13 M | |||
| Total Asset | 7.69 M | |||
| Retained Earnings | (18.05 M) | |||
| Working Capital | 334.24 K | |||
| Net Asset | 7.69 M |
Pair Trading with Altamira Therapeutics
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Altamira Therapeutics position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Altamira Therapeutics will appreciate offsetting losses from the drop in the long position's value.The ability to find closely correlated positions to Laboratory could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Laboratory when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Laboratory - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Laboratory of to buy it.
The correlation of Laboratory is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Laboratory moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Laboratory moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Laboratory can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate. You can also try the Portfolio File Import module to quickly import all of your third-party portfolios from your local drive in csv format.
Other Consideration for investing in Altamira Stock
If you are still planning to invest in Altamira Therapeutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Altamira Therapeutics' history and understand the potential risks before investing.
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance |